MediPharm Labs
MediPharm Labs is a Canadian GMP-certified pharmaceutical cannabis extraction and manufacturing company that produces cannabinoid APIs, white-label products, and branded consumer goods for licensed producers, provincial retailers, and international medical markets across 10 countries.
- Company typePublic
- Founded2017
- HeadquartersBarrie, Canada
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What MediPharm Labs does
MediPharm Labs Corp. is a Canadian pharmaceutical-grade cannabis extraction and manufacturing company headquartered in Barrie, Ontario. Founded in 2017 and listed on the TSX under the ticker LABS, the company operates a 70,000 sq. ft. GMP-certified manufacturing facility with ISO cleanrooms and holds the first Drug Establishment License issued in North America for cannabis-based APIs and pharmaceutical drug products. Its core technology stack is supercritical CO2 extraction paired with short-path wiped-film distillation (capable of >80% purity) and centrifugal partition chromatography for cannabinoid isolation, producing pharmaceutical-grade cannabis inputs rather than commodity-grade extracts.
The company operates a multi-channel B2B and B2C business model. Revenue streams include (1) bulk wholesale GMP cannabis API (concentrates, distillates, isolates) sold to licensed producers, pharma, cosmetics, food and beverage, and nutraceutical companies on quote-based multi-year contracts; (2) white label extraction, distillation, formulation, and packaging services; (3) branded consumer products (oils, soft chews, capsules, vapes, metered-dose inhalers) distributed through Canadian provincial retailers and medical cannabis channels; and (4) GMP-certified clinical trial materials supplied to academic and research institutions. Pricing for B2B is quote-based while consumer pricing is set by provincial retailers.
MediPharm distributes internationally through channel partners in 10 countries including Australia, Germany (Beacon Medical, Wildlife), France, Brazil, New Zealand, and Costa Rica (Remidose LATAM). The April 2023 all-equity acquisition of VIVO Cannabis expanded the combined entity to over CA$50M in annual revenue and added the Beacon Medical and Wildlife brands for international markets. As of Q1 2026, international medical cannabis represented 56% of total revenue and was growing 83% year-over-year. The company employs 101-250 staff, is virtually debt-free with $9.9M in cash, and recently achieved positive adjusted EBITDA under a newly appointed interim CEO.
MediPharm Labs firmographics
Firmographics- Name
- MediPharm Labs
- Legal name
- MediPharm Labs Corp.
- Website
- https://medipharmlabs.com
- Company type
- Public
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- MediPharm Labs is a Canadian GMP-certified pharmaceutical cannabis extraction and manufacturing company that produces cannabinoid APIs, white-label products, and branded consumer goods for licensed producers, provincial retailers, and international medical markets across 10 countries.
- Ownership category
- akta.pro rank
MediPharm Labs industry classification
Industry- Product category
- Pharmaceutical Cannabis Manufacturing
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
- akta.pro secondary industry
- GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)
Keywords
Where MediPharm Labs is headquartered
LocationHeadquarters
- HQ city
- Barrie
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
MediPharm Labs business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- GMP Cannabis API Wholesale: Bulk wholesale offerings including concentrate, distillate, and isolate products in various cannabinoid ratios sold to licensed producers, pharmaceutical companies, cosmetics, food & beverage, and nutraceutical companies.
- White Label Production: Custom extraction, distillation, formulation, sensory testing, packaging, labelling, and distribution services for white label clients including licensed producers.
- Branded Consumer Products: Pharma-quality branded products including formulated oils (CBD25, CBD50, CBD100, THC30, CBN1:2), soft chews, capsules, vapes, and inhalers sold through Canadian provincial retailers and medical channels.
- Clinical Trial Materials: Supply of GMP-certified cannabis products for clinical trials including regulatory support documentation for Health Canada and international clinical trial applications.
- International Medical Cannabis: Export of GMP-certified medicinal cannabis products including oils, tinctures, metered dose inhalers, and dried flower to international markets including Australia, Germany, France, Brazil, New Zealand, and Costa Rica.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B wholesale and white label production services |
| Unit Pricing | Pay-as-you-go | Branded consumer products through provincial retailers |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels5 records
MediPharm Labs product offering
Product offeringCore offering
MediPharm Labs is a pharmaceutical manufacturer specializing in GMP-certified cannabis extraction, purification, and formulation, producing bulk wholesale cannabinoid active pharmaceutical ingredients (API), distillates, and isolates. The company offers white label extraction, distillation, formulation, packaging, and distribution services to licensed producers, and sells its own branded line of formulated oils, soft chews, capsules, vapes, and metered-dose inhalers through Canadian provincial retailers and international medical cannabis channels.
Differentiator
Problem solved
Functional benefit
Brands
- Beacon Medical: Medical cannabis brand serving international markets including Germany and New Zealand
- Wildlife
Products and services
- GMP Cannabis API
- White Label Cannabis Production
- MediPharm Labs Branded Consumer Cannabis Products
Quantifiable outcome
- First Drug Establishment License holder in North America for cannabis API sales
- +3 more outcomes
Companies that use MediPharm Labs
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
MediPharm Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
MediPharm Labs partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Remidose LATAM SRLcoreDefinitive supply agreement for export of GMP-certified medicinal cannabis products including oils, tinctures, metered dose inhalers, and dried flower into Costa Rica's newly opened medical cannabis market. Remidose LATAM holds full licensing and authorization from Costa Rican health authorities. Costa Rica's market is projected to exceed US$35 million annually.
- International Medicinal Cannabis OrganizationcoreProduction agreement with an international medicinal cannabis organization for MediPharm's first shipment to France, marking entry into Europe's emerging medical cannabis market. The agreement enables MediPharm to meet strict European regulatory standards while expanding global footprint.
- VIVO Cannabis Inc.coreMediPharm Labs completed acquisition of VIVO Cannabis Inc. in an all-equity transaction, creating a combined entity with expanded international and Canadian market presence. The ownership ratio is approximately 73.1% for MediPharm shareholders and 26.9% for VIVO shareholders. Deal includes integration of VIVO's brands and operations with targeted annual synergies of CA$7-9 million.
- McMaster UniversitycoreMediPharm Labs has partnered with McMaster University for multiple approved clinical trials in indications including depression-related sleep disorders, post-surgical pain treatment, and opioid sparing in chronic pain. The partnership includes provision of clinical trial materials with regulatory support documentation for Health Canada submissions.
- University Health Network (Toronto)coreAcademic partnership with Toronto's University Health Network leveraging MediPharm's pharmaceutical experience with leading healthcare professionals researching cannabis-derived therapies.
- Loyalist Collegeminor4-year partnership commitment with Loyalist College including access to applied research opportunities, donation of $100,000 of cannabis derivatives towards study, hiring of interns, and hosting annual cohort for educational lectures. Advancing understanding of cannabis-based medicines.
- Beacon Medical / Wildlife (Germany)corePartnership with German distributors Beacon Medical and Wildlife for product portfolio expansion in Germany, supporting 14% sequential revenue growth in Q1 2026.
Scale indicators15 records
Recent moves6 records
Expansion highlights6 records
MediPharm Labs competitors and assessment
Company assessmentBroad incumbents
- Canopy Growth Corporation: Canadian cannabis producer with global medical cannabis operations and CPG brands. Comparable on GMP manufacturing, branded consumer products, and international distribution, though it is in restructuring and significantly larger than MediPharm.
- Tilray Brands: Large multi-jurisdiction cannabis operator with cultivation, processing, branded products, and pharma exposure (including Manitoba Harvest and medical cannabis). Comparable to MediPharm on cannabis manufacturing and international medical distribution, though at far greater scale and with a wider product portfolio.
- Aurora Cannabis: Major Canadian licensed producer with GMP-certified cultivation, processing, and a focus on medical cannabis across Canada and Europe. Comparable on GMP manufacturing, medical cannabis focus, and international regulatory expertise.
- Cronos Group: Canadian cannabis operator with international footprint and a focus on branded products and cannabinoid research, including a strategic partnership with Altria. Comparable on GMP operations and international medical distribution, though more consumer-brand focused.
- Jazz Pharmaceuticals (GW Pharmaceuticals): Owns Epidiolex, the first FDA-approved plant-derived cannabinoid prescription drug, and operates GMP-grade cannabis botanical drug substance manufacturing. Comparable on pharma-grade cannabinoid drug manufacturing and clinical/commercial regulatory pathways.
Direct peers
- OrganiGram Holdings: Canadian licensed producer with GMP-certified manufacturing, branded consumer products, and international medical cannabis operations. Closely comparable in scale, GMP positioning, and medical/consumer split.
- The Valens Company: Canadian cannabis extraction specialist and white-label manufacturer producing cannabis concentrates, infused beverages, and pharma-grade products. Directly comparable on extraction-led business model, white label services, and B2B cannabis API offerings.
- VIVO Cannabis (now part of MediPharm): Canadian licensed producer with Canna Farms medical brand and Beacon Medical/Wildlife international brands. Acquired by MediPharm in 2023; now a subsidiary providing direct comparability on cultivation, branded products, and international medical distribution.
- Charlotte's Web Holdings: CBD-focused branded cannabis wellness products company with cultivation, extraction, and consumer product lines. Comparable on extraction-to-product manufacturing model and branded CBD/THC product portfolio in regulated markets.
- Clever Leaves: Multi-jurisdiction cannabis operator focused on GMP-certified cultivation, extraction, and B2B API/finished product supply to international markets including Europe, Latin America, and Australia. Closely comparable on B2B pharma-grade cannabis API model and international medical distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
MediPharm Labs social profiles
Digital presenceMediPharm Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
MediPharm Labs leadership team
Management profileNumber of profiles
Profiles6 records
MediPharm Labs subsidiaries and ownership
Company hierarchySubsidiaries1 record
MediPharm Labs funding detail
Funding detailFunding overview
Funding rounds4 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MediPharm Labs M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MediPharm Labs
What does MediPharm Labs do?
MediPharm Labs is a pharmaceutical manufacturer specializing in GMP-certified cannabis extraction, purification, and formulation, producing bulk wholesale cannabinoid active pharmaceutical ingredients (API), distillates, and isolates. The company offers white label extraction, distillation, formulation, packaging, and distribution services to licensed producers, and sells its own branded line of formulated oils, soft chews, capsules, vapes, and metered-dose inhalers through Canadian provincial retailers and international medical cannabis channels.
Is MediPharm Labs a public or private company?
MediPharm Labs is a public company. It is classified as public and is currently operating.
When was MediPharm Labs founded?
MediPharm Labs was founded in 2017. It employs 101 to 250 people.
Where is MediPharm Labs based?
MediPharm Labs is headquartered in Barrie, Canada, in the North America region.
How does MediPharm Labs make money?
Five revenue lines are on record. GMP Cannabis API Wholesale is the primary driver. The others are white Label Production, branded Consumer Products, clinical Trial Materials and international Medical Cannabis.
Who are MediPharm Labs's main competitors?
Broad incumbents on record are Canopy Growth Corporation, Tilray Brands, Aurora Cannabis, Cronos Group and Jazz Pharmaceuticals (GW Pharmaceuticals). Direct peers are OrganiGram Holdings, The Valens Company, VIVO Cannabis (now part of MediPharm), Charlotte's Web Holdings and Clever Leaves.
Does MediPharm Labs have an API?
No public API is recorded for MediPharm Labs.
What industry is MediPharm Labs in?
MediPharm Labs's product category is Pharmaceutical Cannabis Manufacturing. Its primary akta.pro industry code is HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC), with a secondary code of HLAGAGAL, GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification). Its NAICS code is 325411 and its SIC code is 2834.